181 related articles for article (PubMed ID: 29623636)
1. An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.
Campbell JA; Hensher M; Neil A; Venn A; Otahal P; Wilkinson S; Palmer AJ
Pharmacoecon Open; 2018 Dec; 2(4):443-458. PubMed ID: 29623636
[TBL] [Abstract][Full Text] [Related]
2. An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients' Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners.
Campbell JA; Hensher M; Neil A; Venn A; Wilkinson S; Palmer AJ
Pharmacoecon Open; 2018 Mar; 2(1):63-76. PubMed ID: 29464671
[TBL] [Abstract][Full Text] [Related]
3. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
[TBL] [Abstract][Full Text] [Related]
4. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
Orji NC; Cox IA; Jason LA; Chen G; Zhao T; Rogerson MJ; Kelly RM; Wills K; Hensher M; Palmer AJ; de Graaff B; Campbell JA
Qual Life Res; 2024 Jan; 33(1):45-57. PubMed ID: 37561337
[TBL] [Abstract][Full Text] [Related]
5. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
[TBL] [Abstract][Full Text] [Related]
6. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ
Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311
[TBL] [Abstract][Full Text] [Related]
7. The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments.
Engel L; Chen G; Richardson J; Mihalopoulos C
Qual Life Res; 2018 Nov; 27(11):2873-2884. PubMed ID: 30006664
[TBL] [Abstract][Full Text] [Related]
8. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia.
Chan HY; Wijnen BFM; Hiligsmann M; Smit F; Leenen LAM; Majoie MHJM; Evers SMAA
Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):795-803. PubMed ID: 34553651
[TBL] [Abstract][Full Text] [Related]
10. Evaluating health-related quality of life and subjective wellbeing among infertility patients: a cross-sectional study in mainland China.
Shi Z; Nie H; Geng L; Wang X; Chen G; Li S
Qual Life Res; 2023 May; 32(5):1469-1480. PubMed ID: 36617607
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
[TBL] [Abstract][Full Text] [Related]
12. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
Richardson J; Khan MA; Iezzi A; Maxwell A
Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
[TBL] [Abstract][Full Text] [Related]
13. Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
Zhang Y; Taylor BV; Simpson S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I
Mult Scler; 2021 Jul; 27(8):1262-1275. PubMed ID: 32924841
[TBL] [Abstract][Full Text] [Related]
14. Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument.
Ahmad H; van der Mei I; Taylor BV; Campbell JA; Palmer AJ
Mult Scler Relat Disord; 2020 Sep; 44():102358. PubMed ID: 32650122
[TBL] [Abstract][Full Text] [Related]
15. Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
Claflin S; Campbell JA; Norman R; Mason DF; Kalincik T; Simpson-Yap S; Butzkueven H; Carroll WM; Palmer AJ; Blizzard CL; van der Mei I; Henson GJ; Taylor BV
Eur J Health Econ; 2023 Aug; 24(6):939-950. PubMed ID: 36149605
[TBL] [Abstract][Full Text] [Related]
16. Patient-Reported Health-Related Quality of Life in Individuals with Inherited Retinal Diseases.
Schofield D; Kraindler J; Tan O; Shrestha R; Jelovic D; West S; Ma A; Grigg J; Jamieson RV
Ophthalmol Sci; 2022 Mar; 2(1):100106. PubMed ID: 36246188
[TBL] [Abstract][Full Text] [Related]
17. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.
Kennedy-Martin M; Slaap B; Herdman M; van Reenen M; Kennedy-Martin T; Greiner W; Busschbach J; Boye KS
Eur J Health Econ; 2020 Nov; 21(8):1245-1257. PubMed ID: 32514643
[TBL] [Abstract][Full Text] [Related]
18. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.
Herdman M; Kerr C; Pavesi M; Garside J; Lloyd A; Cubi-Molla P; Devlin N
J Patient Rep Outcomes; 2020 Mar; 4(1):22. PubMed ID: 32219576
[TBL] [Abstract][Full Text] [Related]
19. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures.
Mihalopoulos C; Chen G; Iezzi A; Khan MA; Richardson J
Br J Psychiatry; 2014 Nov; 205(5):390-7. PubMed ID: 25257063
[TBL] [Abstract][Full Text] [Related]
20. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia.
Pan T; Wu Y; Buchanan J; Goranitis I
Health Qual Life Outcomes; 2023 Dec; 21(1):132. PubMed ID: 38087302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
